These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10103180)

  • 1. Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice.
    Jenks PJ; Labigne A; Ferrero RL
    Antimicrob Agents Chemother; 1999 Apr; 43(4):777-81. PubMed ID: 10103180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.
    Jenks PJ; Ferrero RL; Tankovic J; Thiberge JM; Labigne A
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2623-9. PubMed ID: 10991835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
    Bardhan K; Bayerdörffer E; Veldhuyzen Van Zanten SJ; Lind T; Mégraud F; Delchier JC; Hellblom M; Stubberöd A; Burman CF; Gromark P; Zeijlon L
    Helicobacter; 2000 Dec; 5(4):196-201. PubMed ID: 11179983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.
    Loughlin MF; Ala'Aldeen DA; Jenks PJ
    J Antimicrob Chemother; 2003 Feb; 51(2):367-71. PubMed ID: 12562704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit.
    Fraser AG; Moore L; Hackett M; Hollis B
    Aust N Z J Med; 1999 Aug; 29(4):512-6. PubMed ID: 10868529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
    Midolo PD; Lambert JR; Turnidge J
    J Gastroenterol Hepatol; 1996 Mar; 11(3):290-2. PubMed ID: 8742929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.
    Matsumoto S; Washizuka Y; Matsumoto Y; Tawara S; Ikeda F; Yokota Y; Karita M
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2602-5. PubMed ID: 9420026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?
    Bazzoli F; Berretti D; De Luca L; Nicolini G; Pozzato P; Fossi S; Zagari M
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S39-42; discussion S43-5. PubMed ID: 10503822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
    Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
    Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.
    Wang WH; Wong BC; Mukhopadhyay AK; Berg DE; Cho CH; Lai KC; Hu WH; Fung FM; Hui WM; Lam SK
    Aliment Pharmacol Ther; 2000 Jul; 14(7):901-10. PubMed ID: 10886046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
    Gomollón F; Ducóns JA; Ferrero M; García Cabezudo J; Guirao R; Simón MA; Montoro M
    Helicobacter; 1999 Dec; 4(4):222-5. PubMed ID: 10597390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
    Lind T; Mégraud F; Unge P; Bayerdörffer E; O'morain C; Spiller R; Veldhuyzen Van Zanten S; Bardhan KD; Hellblom M; Wrangstadh M; Zeijlon L; Cederberg C
    Gastroenterology; 1999 Feb; 116(2):248-53. PubMed ID: 9922303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
    Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.